Klein; Peter S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klein; Peter S..The latest application filed is for "in vivo and ex vivo expansion of hematopoietic stem cells with a targeted combination of clinically tested, fda approved drugs".

Company Profile

1.5.7

Klein; Peter S. - Wynnewood PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs App 20190167728 - Klein; Peter S. ; et al.	2019-06-06
In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs App 20170065640 - Klein; Peter S. ; et al.	2017-03-09
In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combination of clinically tested, FDA approved drugs Grant 9,452,187 - Klein , et al. September 27, 2	2016-09-27
In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs App 20150272995 - Klein; Peter S. ; et al.	2015-10-01
In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combination of clinically tested, FDA approved drugs Grant 9,050,315 - Klein , et al. June 9, 2	2015-06-09
In Vivo and Ex Vivo Expansion of Hematopoietic Stem Cells With a Targeted Combination of Clinically Tested, FDA Approved Drugs App 20110251593 - Klein; Peter S. ; et al.	2011-10-13
Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's disease App 20100068308 - Phiel; Christopher J. ; et al.	2010-03-18
Regulation of GSK-3.alpha. activity for the treatment or prevention of Alzheimer's disease Grant 7,378,111 - Phiel , et al. May 27, 2	2008-05-27
Regulation of GSK-3alpha activity for the treatment or prevention of Alzheimer's disease App 20040110837 - Phiel, Christopher J. ; et al.	2004-06-10
Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same Grant 6,441,053 - Klein , et al. August 27, 2	2002-08-27
Axin domain-like polypeptide inhibitors of glycogen synthase kinase 3 beta activity and activators of wnt signaling App 20010052137 - Klein, Peter S.	2001-12-13

Company Registrations

CAGE Code	4H2J1	KLEIN, PETER S END USER
SEC	0001478007	Klein Peter S

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.